ClinicalCodes.org

An online clinical codes repository to improve validity and reproducibility of medical database research

Research article:

Incidence, clinical management, and mortality risk following self-harm among children and adolescents: cohort study in primary care

Reference:

C Morgan, RT Webb, MJ Carr, E Kontopantelis, J Green, CA Chew-Graham, N Kapur, DM Ashcroft (2017) Incidence, clinical management, and mortality risk following self-harm among children and adolescents: cohort study in primary care. The BMJ, doi: doi.org/10.1136/bmj.j4351

Link to fulltext article
Abstract
Abstract Objectives To examine temporal trends in sex and age specific incidence of self harm in children and adolescents, clinical management patterns, and risk of cause specific mortality following an index self harm episode at a young age. Design Population based cohort study. Setting UK Clinical Practice Research Datalink—electronic health records from 674 general practices, with practice level deprivation measured ecologically using the index of multiple deprivation. Patients from eligible English practices were linked to hospital episode statistics (HES) and Office for National Statistics (ONS) mortality records. Participants For the descriptive analytical phases we examined data pertaining to 16 912 patients aged 10-19 who harmed themselves during 2001-14. For analysis of cause specific mortality following self harm, 8638 patients eligible for HES and ONS linkage were matched by age, sex, and general practice with up to 20 unaffected children and adolescents (n=170 274). Main outcome measures In the first phase, temporal trends in sex and age specific annual incidence were examined. In the second phase, clinical management was assessed according to the likelihood of referral to mental health services and psychotropic drug prescribing. In the third phase, relative risks of all cause mortality, unnatural death (including suicide and accidental death), and fatal acute alcohol or drug poisoning were estimated as hazard ratios derived from stratified Cox proportional hazards models for the self harm cohort versus the matched unaffected comparison cohort. Results The annual incidence of self harm was observed to increase in girls (37.4 per 10 000) compared with boys (12.3 per 10 000), and a sharp 68% increase occurred among girls aged 13-16, from 45.9 per 10 000 in 2011 to 77.0 per 10 000 in 2014. Referrals within 12 months of the index self harm episode were 23% less likely for young patients registered at the most socially deprived practices, even though incidences were considerably higher in these localities. Children and adolescents who harmed themselves were approximately nine times more likely to die unnaturally during follow-up, with especially noticeable increases in risks of suicide (deprivation adjusted hazard ratio 17.5, 95% confidence interval 7.6 to 40.5) and fatal acute alcohol or drug poisoning (34.3, 10.2 to 115.7). Conclusions Gaining a better understanding of the mechanisms responsible for the recent apparent increase in the incidence of self harm among early-mid teenage girls, and coordinated initiatives to tackle health inequalities in the provision of services to distressed children and adolescents, represent urgent priorities for multiple public agencies.
Author for correspondence
Catharine Morgan
Email for correspondence
cathy.morgan@manchester.ac.uk

Code list: res55: antidepressant

42 codes in list

Code Coding system Description Entity type List name
d7.. Read tricylcic antidepressants drug res55: antidepressant
d71.. Read amitriptyline hcl [antidepres] drug res55: antidepressant
d72.. Read butriptyline drug res55: antidepressant
d73.. Read clomipramine hydrochloride drug res55: antidepressant
d74.. Read desipramine drug res55: antidepressant
d75.. Read dosulepin hydrochloride drug res55: antidepressant
d76.. Read doxepin drug res55: antidepressant
d77.. Read imipramine hcl [antidepress] drug res55: antidepressant
d78.. Read iprindole drug res55: antidepressant
d79.. Read lofepramine drug res55: antidepressant
d7a.. Read maprotiline drug res55: antidepressant
d7b.. Read mianserin hydrochloride drug res55: antidepressant
d7c.. Read nortriptyline drug res55: antidepressant
d7d.. Read protriptyline drug res55: antidepressant
d7e.. Read trazodone hydrochloride drug res55: antidepressant
d7f.. Read trimipramine drug res55: antidepressant
d7g.. Read viloxazine drug res55: antidepressant
d7h.. Read amoxapine drug res55: antidepressant
d8.. Read monoamine-oxidase inhibitors drug res55: antidepressant
d81.. Read phenelzine drug res55: antidepressant
d82.. Read iproniazid drug res55: antidepressant
d83.. Read isocarboxazid drug res55: antidepressant
d84.. Read tranylcypromine drug res55: antidepressant
d85.. Read moclobemide drug res55: antidepressant
d9.. Read compound antidepressant drugs drug res55: antidepressant
da.. Read other antidepressant drugs drug res55: antidepressant
da2.. Read tryptophan drug res55: antidepressant
da3.. Read fluvoxamine maleate drug res55: antidepressant
da4.. Read fluoxetine hydrochloride drug res55: antidepressant
da5.. Read sertraline hydrochloride drug res55: antidepressant
da6.. Read paroxetine hydrochloride drug res55: antidepressant
da7.. Read venlafaxine drug res55: antidepressant
da8. Read nefazodone drug res55: antidepressant
da9.. Read citalopram drug res55: antidepressant
daA.. Read reboxetine drug res55: antidepressant
daB.. Read mirtazapine drug res55: antidepressant
daC.. Read escitalopram drug res55: antidepressant
daD.. Read agomelatine drug res55: antidepressant
daE. Read vortioxetine drug res55: antidepressant
gd1.. Read *amitriptyline hcl [enuresis] drug res55: antidepressant
gd5.. Read *imipramine hcl [enuresis] drug res55: antidepressant
gde.. Read duloxetine drug res55: antidepressant

0 comments have been posted.

Please log in to leave a comment.